Current evaluation of alemtuzumab in multiple sclerosis

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.14, Iss.1, 2014-01, pp. : 127-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alemtuzumab and multiple sclerosis: therapeutic application

By Alireza Minagar J Steven Alexander Mohammad Ali Sahraian Robert Zivadinov

Expert Opinion on Biological Therapy, Vol. 10, Iss. 3, 2010-03 ,pp. : 421-429

Informa Healthcare

Access to resources Recommend Favorite

Tovaxin for multiple sclerosis

By Rivera Victor M

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 961-967

Informa Healthcare

Access to resources Recommend Favorite

On the Catalytic Activity of Autoantibodies in Multiple Sclerosis

By Ponomarenko N. A. Durova O. M. Vorob'ev I. I. Suchkov S. V. Gabibov A. G.

Doklady Biochemistry & Biophysics, Vol. 395, Iss. 1-6, 2004-03 ,pp. : 120-123

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Spasticity in multiple sclerosis: results of a patient survey

By Oreja-Guevara C.

International Journal of Neuroscience, Vol. 123, Iss. 6, 2013-04 ,pp. : 400-408

Informa Healthcare

Access to resources Recommend Favorite

Neutralising antibodies to IFN-&bgr; in patients with multiple sclerosis

By Bagnato Francesca Riva Marco Antonelli Guido

Expert Opinion on Biological Therapy, Vol. 6, Iss. 8, 2006-08 ,pp. : 773-785

Informa Healthcare

Access to resources Recommend Favorite